NA
ACH

Navellier & Associates’s Accendra Health ACH Stock Holding History

Navellier & Associates’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-39,762
Closed -$1.75M – 318
2022
Q1 		$1.75M Sell
39,762
-539
-1% -$23.1K 0.3% 98
2021
Q4 		$1.75M Buy
40,301
+3,424
+9% +$134K 0.26% 103
2021
Q3 		$1.15M Buy
36,877
+16,658
+82% +$656K 0.17% 131
2021
Q2 		$856K Buy
+20,219
New +$787K 0.13% 153

Other funds holding ACH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Navellier & Associates's ACH Position: Q2 2022 in Review

Navellier & Associates sold out of Accendra Health (ACH) in Q2 2022, closing a stake of 39,762 shares — an estimated $1.75M sold.

Navellier & Associates first reported a position in ACH in Q2 2021 and held it in 4 quarters. The position peaked at $1.75M in Q4 2021. 251 funds tracked by Wall St. Rank hold ACH as of Q2 2022.

  • Navellier & Associates reported no remaining Accendra Health position as of Q2 2022 after selling out during the quarter.
  • Navellier & Associates sold 39,762 Accendra Health shares in Q2 2022, an estimated $1.75M.
  • Navellier & Associates first reported a position in Accendra Health in Q2 2021 and held it in 4 quarters.
  • Navellier & Associates's Accendra Health position peaked at $1.75M in Q4 2021.
  • 251 funds tracked by Wall St. Rank held Accendra Health as of Q2 2022.

Based on Navellier & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.